临床荟萃

• 专题 • 上一篇    下一篇

2018年风湿病学主要临床进展

  

  1. 河北医科大学第二医院 风湿免疫科, 河北 石家庄 050000
  • 出版日期:2019-01-20 发布日期:2019-01-30
  • 通讯作者: 通信作者:郭惠芳,Email:guohfch@ 126.com
  • 作者简介:高丽霞,女,河北医科大学第二医院风湿免疫科主任医师,医学博士,硕士生导师。中华医学会风湿病学分会第九届青年委员,河北省免疫学会风湿免疫专业委员会委员,河北省医师协会风湿病分会委员,河北省免疫吸附学组委员。长期从事风湿病学临床、科研和教学工作,曾在国内外专业杂志上发表SCI、核心期刊文章共40余篇,独立承担省级厅级科研项目5项,获省科技进步奖等科技成果奖3项。

Major advances in clinical research of rheumatic diseases of  2018

  1. Department of Rheumatology and Immunology,  the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Online:2019-01-20 Published:2019-01-30
  • Contact: Corresponding author: Guo Huifang, Email: guohfch@ 126.com

摘要: 018年系统性红斑狼疮、类风湿关节炎及银屑病关节炎等多个国家多个管理指南相继推出, 风湿病的治疗越来越详细规范, 不仅关注系统性疾病,而且对于单一器官单一症状的指南也接踵而至。药物治疗更加慎重,除以往的使用指征,扩展到筛查感染、肿瘤以及共患病管理等多个方面。多学科合作成为趋势,诊断中的影像学检查、治疗中的非药物治疗以及患者的心理需求都受到关注,甚至疾病分类命名也列入了章程。临床研究的关注度日趋上升,尤其生物制剂的研究备受关注。

关键词: 红斑狼疮, 系统性, 关节炎, 血管炎, 高尿酸血症, 自身炎症性疾病

Abstract: The year 2018 witnessed the introduction of  multiple management guidelines for systemic lupus erythematosus,  rheumatoid arthritis and psoriatic arthritis.  The treatment of rheumatic disease also went into more details which not only focused on systemic diseases,  but also on single organ and symptom. And the related guidelines are also coming. Drug treatment is more cautious and extends to the screening of infection,  cancer and comorbidity  management.   Multidisciplinary cooperation has become a trend. And imaging examinations in diagnosis,  nondrug therapies  and psychological needs of patients in treatment have all received attention.  The classification of diseases also has been placed on the agenda.  The clinical researches is attracting more and more public attention,  especially in terms of the study of biological agents.

Key words: erythematosus lupus, systemic, arthritis;vasculitis, hyperuricemia, autoinflammatory diseases